Gesplicet

Gesplicet is a Dutch term used in molecular biology to describe RNA that has undergone the splicing process, in which noncoding sequences called introns are removed and the remaining coding sequences, exons, are joined to form mature messenger RNA. Splicing is a post-transcriptional modification occurring mainly in the nucleus and is essential for proper gene expression in eukaryotes. Many genes can be spliced in alternative ways, generating multiple mRNA and protein isoforms from a single gene.

Mechanism and components: Splicing is carried out by the spliceosome, a complex of small nuclear RNAs and proteins. It recognizes conserved sequences at exon-intron boundaries, including donor and acceptor sites, selects a branch point, and creates a lariat intermediate before ligating exons together. Canonical splice site motifs and regulatory elements guide the process, enabling either constitutive splicing or alternative splicing, where different exon combinations produce diverse transcripts.

Biological significance: Splicing shapes the transcriptome and proteome. A large majority of human multi-exon genes are subject to alternative splicing, which increases protein diversity and regulates gene expression in development and tissue specificity. Errors in splicing can have pathogenic consequences, contributing to genetic disorders and cancer.

Applications and relevance: Understanding gesplicet informs research on gene regulation, evolution, and disease. Techniques such as RNA sequencing and RT-PCR detect splicing patterns, while therapeutic approaches use splice-switching strategies—such as antisense oligonucleotides—to correct or modify splicing in disease contexts. Examples include treatments aimed at promoting exon inclusion or skipping to restore functional proteins.

See also: RNA splicing, spliceosome, intron, exon, alternative splicing.